Evaluating Symptom Clusters in Patients with Breast Cancer Experiencing Aromatase Inhibitor-Associated Musculoskeletal Symptoms

被引：0
|
作者：
Nicole, Fleege
Henry, N. Lynn
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO1-11-06
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO1-11-06
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Aromatase inhibitor-associated musculoskeletal pain: taking 'AIM' at a symptom in breast cancer survivors
    Henry, N. Lynn
    [J]. PAIN MANAGEMENT, 2011, 1 (03) : 191 - 193
  • [2] Aromatase Inhibitor-Associated Musculoskeletal Symptoms #402
    Chang, Philip J.
    [J]. JOURNAL OF PALLIATIVE MEDICINE, 2020, 23 (11) : 1542 - 1543
  • [3] Aromatase inhibitor-associated musculoskeletal symptoms: incidence and associated factors
    Park, Jin Young
    Lee, Se Kyung
    Bee, Soo Youn
    Kim, Jiyoung
    Kim, Min Kuk
    Kil, Won Ho
    Lee, Jeong Eon
    Nam, Seok Jin
    [J]. JOURNAL OF THE KOREAN SURGICAL SOCIETY, 2013, 85 (05): : 205 - 211
  • [4] Management of aromatase inhibitor-associated musculoskeletal symptoms: A systematic review
    Roberts, Kate
    Rickett, Kirsty
    Woodward, Natasha E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (03)
  • [5] Aromatase Inhibitor-Associated Musculoskeletal Symptoms: Etiology and Strategies for Management
    Henry, N. Lynn
    Giles, Jon T.
    Stearns, Vered
    [J]. ONCOLOGY-NEW YORK, 2008, 22 (12): : 1401 - 1408
  • [6] Factors associated with aromatase inhibitor associated musculoskeletal symptoms in early stage breast cancer patients
    Sun, Yamin
    Elder, Simran
    Jung, Seungyoun
    Mainor, Candace
    Murali, Shruti
    Rosenblatt, Paula
    Tkaczuk, Katherine
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [7] Association of Aromatase Inhibitor-Associated Musculoskeletal Symptoms with Ultrasonographic Changes at the Wrist
    Henry, N. L.
    Jacobson, J.
    Banerjee, M.
    Hayden, J.
    Smerage, J.
    Stearns, V
    Hayes, D. F.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 527S - 527S
  • [8] Pilot study of duloxetine for treatment of aromatase inhibitor-associated musculoskeletal symptoms
    Henry, N. Lynn
    Banerjee, Mousumi
    Wicha, Max
    Van Poznak, Catherine
    Smerage, Jeffrey B.
    Schott, Anne F.
    Griggs, Jennifer J.
    Hayes, Daniel F.
    [J]. CANCER, 2011, 117 (24) : 5469 - 5475
  • [9] TRAJECTORIES OF AROMATASE INHIBITOR-ASSOCIATED MUSCULOSKELETAL SYMPTOMS ( AIAMS) FOR BREAST CANCER: 18-MONTH FOLLOW-UP
    Zhu, Yehui
    Sereika, Susan
    Merriman, John
    Bender, Catherine
    [J]. ONCOLOGY NURSING FORUM, 2017, 44 (02)
  • [10] Predictors of Pain Reduction in Trials of Interventions for Aromatase Inhibitor-Associated Musculoskeletal Symptoms
    Henry, N. Lynn
    Unger, Joseph M.
    Till, Cathee
    Crew, Katherine D.
    Fisch, Michael J.
    Hershman, Dawn L.
    [J]. JNCI CANCER SPECTRUM, 2021, 5 (06)
12345